Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation

While Botulinum NeuroToxin-A (BoNT-A) injections are frequently used to reduce the effects of hyperactive stretch reflexes in children with cerebral palsy (CP), the effects of this treatment vary strongly. Previous research, combining electromyography (EMG) with motion analysis, defined different pa...

Full description

Bibliographic Details
Main Authors: Lynn Bar-On, Erwin Aertbeliën, Anja Van Campenhout, Guy Molenaers, Kaat Desloovere
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00378/full
_version_ 1828261263317139456
author Lynn Bar-On
Lynn Bar-On
Erwin Aertbeliën
Erwin Aertbeliën
Anja Van Campenhout
Anja Van Campenhout
Guy Molenaers
Guy Molenaers
Kaat Desloovere
Kaat Desloovere
author_facet Lynn Bar-On
Lynn Bar-On
Erwin Aertbeliën
Erwin Aertbeliën
Anja Van Campenhout
Anja Van Campenhout
Guy Molenaers
Guy Molenaers
Kaat Desloovere
Kaat Desloovere
author_sort Lynn Bar-On
collection DOAJ
description While Botulinum NeuroToxin-A (BoNT-A) injections are frequently used to reduce the effects of hyperactive stretch reflexes in children with cerebral palsy (CP), the effects of this treatment vary strongly. Previous research, combining electromyography (EMG) with motion analysis, defined different patterns of stretch reflex muscle activation in muscles, those that reacted more to a change in velocity (velocity dependent –VD), and those that reacted more to a change in length (length dependent –LD). The aim of this study was to investigate the relation between the types of stretch reflex muscle activation in the semitendinosus with post-BoNT-A outcome as assessed passively and with 3D gait analysis in children with spastic CP. Eighteen children with spastic CP (10 bilaterally involved) between the ages of 12 and 18 years were assessed before and on average, 8 weeks post-treatment. EMG and motion analysis were used to assess the degree and type of muscle activation dependency in the semitendinosus during passive knee extensions performed at different joint angular velocities. Three-dimensional gait analysis was used to assess knee gait kinematics as a measure of functional outcome. Pre-treatment, 9 muscles were classified as VD and 9 as LD, but no differences between the groups were evident in the baseline knee gait kinematics. Post-treatment, stretch reflex muscle activation decreased significantly in both groups but the reduction was more pronounced in those muscles classified pre-treatment as VD (−72% vs. −50%, p = 0.005). In the VD group, these changes were accompanied by greater knee extension at initial contact and during the swing phase of gait. In the LD group, there was significantly increased post-treatment knee hyperextension in late stance. Although results vary between patients, the reduction of stretch reflex muscle activation in the semitendinosus generally translated to an improved functional outcome, as assessed with 3D gait analysis. However, results were less positive for those muscles with pre-treatment length-dependent type of stretch reflex muscle activation. The study demonstrates the relevance of categorizing the type of stretch reflex muscle activation as a possible predictor of treatment response.
first_indexed 2024-04-13T03:38:03Z
format Article
id doaj.art-5927e521955b4676841f819846326682
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-13T03:38:03Z
publishDate 2020-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-5927e521955b4676841f8198463266822022-12-22T03:04:17ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-06-011110.3389/fneur.2020.00378515964Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle ActivationLynn Bar-On0Lynn Bar-On1Erwin Aertbeliën2Erwin Aertbeliën3Anja Van Campenhout4Anja Van Campenhout5Guy Molenaers6Guy Molenaers7Kaat Desloovere8Kaat Desloovere9Department of Rehabilitation Medicine, Amsterdam UMC, Amsterdam Movement Sciences, Amsterdam, NetherlandsDepartment of Rehabilitation Sciences, KU Leuven, Leuven, BelgiumDepartment of Mechanical Engineering, KU Leuven, Leuven, BelgiumROB Core Lab, Flanders Make, Leuven, BelgiumDepartment of Development and Regeneration, KU Leuven, Leuven, BelgiumClinical Motion Analysis Laboratory, University Hospital Leuven, Leuven, BelgiumDepartment of Development and Regeneration, KU Leuven, Leuven, BelgiumClinical Motion Analysis Laboratory, University Hospital Leuven, Leuven, BelgiumDepartment of Rehabilitation Sciences, KU Leuven, Leuven, BelgiumClinical Motion Analysis Laboratory, University Hospital Leuven, Leuven, BelgiumWhile Botulinum NeuroToxin-A (BoNT-A) injections are frequently used to reduce the effects of hyperactive stretch reflexes in children with cerebral palsy (CP), the effects of this treatment vary strongly. Previous research, combining electromyography (EMG) with motion analysis, defined different patterns of stretch reflex muscle activation in muscles, those that reacted more to a change in velocity (velocity dependent –VD), and those that reacted more to a change in length (length dependent –LD). The aim of this study was to investigate the relation between the types of stretch reflex muscle activation in the semitendinosus with post-BoNT-A outcome as assessed passively and with 3D gait analysis in children with spastic CP. Eighteen children with spastic CP (10 bilaterally involved) between the ages of 12 and 18 years were assessed before and on average, 8 weeks post-treatment. EMG and motion analysis were used to assess the degree and type of muscle activation dependency in the semitendinosus during passive knee extensions performed at different joint angular velocities. Three-dimensional gait analysis was used to assess knee gait kinematics as a measure of functional outcome. Pre-treatment, 9 muscles were classified as VD and 9 as LD, but no differences between the groups were evident in the baseline knee gait kinematics. Post-treatment, stretch reflex muscle activation decreased significantly in both groups but the reduction was more pronounced in those muscles classified pre-treatment as VD (−72% vs. −50%, p = 0.005). In the VD group, these changes were accompanied by greater knee extension at initial contact and during the swing phase of gait. In the LD group, there was significantly increased post-treatment knee hyperextension in late stance. Although results vary between patients, the reduction of stretch reflex muscle activation in the semitendinosus generally translated to an improved functional outcome, as assessed with 3D gait analysis. However, results were less positive for those muscles with pre-treatment length-dependent type of stretch reflex muscle activation. The study demonstrates the relevance of categorizing the type of stretch reflex muscle activation as a possible predictor of treatment response.https://www.frontiersin.org/article/10.3389/fneur.2020.00378/fullcerebral palsystretch reflexspasticitygait analysisBotulinum toxintreatment
spellingShingle Lynn Bar-On
Lynn Bar-On
Erwin Aertbeliën
Erwin Aertbeliën
Anja Van Campenhout
Anja Van Campenhout
Guy Molenaers
Guy Molenaers
Kaat Desloovere
Kaat Desloovere
Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
Frontiers in Neurology
cerebral palsy
stretch reflex
spasticity
gait analysis
Botulinum toxin
treatment
title Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
title_full Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
title_fullStr Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
title_full_unstemmed Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
title_short Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
title_sort treatment response to botulinum neurotoxin a in children with cerebral palsy categorized by the type of stretch reflex muscle activation
topic cerebral palsy
stretch reflex
spasticity
gait analysis
Botulinum toxin
treatment
url https://www.frontiersin.org/article/10.3389/fneur.2020.00378/full
work_keys_str_mv AT lynnbaron treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT lynnbaron treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT erwinaertbelien treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT erwinaertbelien treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT anjavancampenhout treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT anjavancampenhout treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT guymolenaers treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT guymolenaers treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT kaatdesloovere treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation
AT kaatdesloovere treatmentresponsetobotulinumneurotoxinainchildrenwithcerebralpalsycategorizedbythetypeofstretchreflexmuscleactivation